OverviewChartProfileKey statisticsFinancialsNewsTraderScreen

Astellas Pharma, Inc./  US04623U1025  /

Nasdaq Other OTC
2024-05-31  9:59:40 PM Chg. +0.1200 Volume Bid- Ask- Market Capitalization Dividend Y. P/E Ratio
9.8100USD +1.24% 508,631
Turnover: 4.95 mill.		 -Bid Size: - -Ask Size: - 21.22 bill.USD - -

Assets

 2021
IFRS
in mill. JPY		 2022
IFRS
in mill. JPY
Property and Equipment
  269,044   286,459
Intangible Assets
  623,431   562,496
Long-Term Investments
  -   -
Fixed Assets
  1.41 mill.   1.41 mill.
Inventories
  153,072   174,386
Accounts Receivable
  412,258   452,138
Cash and Cash Equivalents
  315,986   376,840
Current Assets
  923,354   1.05 mill.
Total Assets
  2.33 mill.   2.46 mill.

 

Liabilities

 2021
IFRS
in mill. JPY		 2022
IFRS
in mill. JPY
Accounts Payable
  131,415   144,453
Long-term debt
  -   -
Liabilities to Banks
  -   -
Provisions
  28,224   30,440
Liabilities
  872,087   948,564
Share Capital
  -   -
Total Equity
  1.46 mill.   1.51 mill.
Minority Interests
  -   -
Total liabilities equity
  2.33 mill.   2.46 mill.

 

Income Statement

 2021
IFRS
in mill. JPY		 2022
IFRS
in mill. JPY
Revenues
  1.3 mill.   1.52 mill.
Depreciation (total)
  28,283   38,436
Operating Result
  155,686   133,029
Interest Income
  1,200   -669
Income Before Taxes
  -   -
Income Taxes
  32,800   33,647
Minority Interests Profit
  -   -
Net Income
  124,086   98,714

 

Per Share

 2021
IFRS
in JPY		 2022
IFRS
in JPY
Earnings per Share
  67.0800   54.2400
Dividend per Share
  -   -

 

Cash Flow

 2021
IFRS
in mill. JPY		 2022
IFRS
in mill. JPY
Cash Flow from Operating Activities
  257,444   327,767
Cash Flow from Investing Activities
  -62,413   -84,500
Cash Flow from Financing
  -216,298   -195,623
Decrease / Increase in Cash
  -   -
Employees
  14,520   14,480